Philippe Bernard

A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou et al. · New England Journal of Medicine · 2002 · 614 citations

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 460 citations

Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions

Philippe Bernard · Archives of Dermatology · 1995 · 437 citations

Allergy, Autoimmune Disease, Skin Testing +14

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Dédée F. Murrell, Benjamin S. Daniel, P. Joly et al. · Journal of the American Academy of Dermatology · 2011 · 365 citations · Full text

Bullous Pemphigoid, Public Health, International Panel +3